PARAMETRIC PORTFOLIO ASSOCIATES LLC - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 110 filers reported holding TG THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
PARAMETRIC PORTFOLIO ASSOCIATES LLC ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$1,059,000
-28.8%
111,362
+42.3%
0.00%0.0%
Q4 2021$1,487,000
-43.3%
78,251
-0.6%
0.00%0.0%
Q3 2021$2,621,000
-48.7%
78,755
-40.2%
0.00%
-66.7%
Q2 2021$5,113,000
-27.8%
131,800
-10.3%
0.00%
-25.0%
Q1 2021$7,080,000
-5.0%
146,878
+2.5%
0.00%
-20.0%
Q4 2020$7,452,000
+97.1%
143,256
+1.4%
0.01%
+66.7%
Q3 2020$3,780,000
+42.4%
141,266
+3.7%
0.00%
+50.0%
Q2 2020$2,654,000
+541.1%
136,250
+223.5%
0.00%
Q1 2020$414,000
-3.3%
42,111
+9.1%
0.00%
Q4 2019$428,000
+289.1%
38,595
+96.5%
0.00%
Q3 2019$110,000
-39.9%
19,639
-7.2%
0.00%
Q2 2019$183,000
+56.4%
21,152
+45.4%
0.00%
Q1 2019$117,000
-88.5%
14,543
-83.0%
0.00%
-100.0%
Q3 2017$1,015,000
+18.2%
85,622
+0.2%
0.00%0.0%
Q2 2017$859,000
-7.4%
85,476
+7.3%
0.00%0.0%
Q1 2017$928,000
+459.0%
79,654
+470.8%
0.00%
Q4 2015$166,000
+5.7%
13,955
-10.6%
0.00%
Q3 2015$157,000
-72.0%
15,618
-53.8%
0.00%
-100.0%
Q2 2015$561,00033,8080.00%
Other shareholders
TG THERAPEUTICS INC shareholders Q4 2017
NameSharesValueWeighting ↓
RA Capital Management 6,880,323$38,633,0002.30%
Eversept Partners, LP 773,501$4,343,2081.35%
Opaleye Management Inc. 612,500$3,439,0001.24%
BRIDGER MANAGEMENT, LLC 2,334,196$13,107,0001.08%
Sofinnova Investments, Inc. 1,733,628$9,734,0000.88%
PURA VIDA INVESTMENTS, LLC 354,719$1,992,0000.34%
683 Capital Management, LLC 400,000$2,246,0000.25%
NEXPOINT ASSET MANAGEMENT, L.P. 649,460$3,646,0000.23%
Artal Group S.A. 900,000$5,054,0000.20%
Frontier Wealth Management LLC 226,750$1,273,0000.19%
View complete list of TG THERAPEUTICS INC shareholders